Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F61E1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,685
Award facts
- Contract value 100% obligated
- $1,685.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Xeljanz XR 11 mg tablets in 30-unit packages, with a contract ceiling value of $1,685.35. This firm fixed price delivery order, set to conclude by November 17, 2025, represents a competitive award under AmerisourceBergen's broader indefinite delivery contract with the DLA. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and serves as a critical vendor for federal medical procurement.
This delivery order falls under AmerisourceBergen's existing $999.999 billion indefinite delivery contract with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery order for Xeljanz XR—a rheumatoid arthritis treatment—exemplifies the company's role in providing specialty medications across multiple therapeutic domains to sustain military medical operations.
Quick answers
Who was awarded contract SPE2DR26F61E1?
SPE2DR26F61E1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F61E1 worth?
The government has obligated $1,685 on SPE2DR26F61E1.
Is contract SPE2DR26F61E1 an order under another contract?
Yes. SPE2DR26F61E1 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F61E1 competed?
The extent of competition for SPE2DR26F61E1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award